TrialX
Image

Associations Between Physical Activity and Sedentary Behavior Profiles and Carotid Intima-media Thickness in Adolescents With Obesity

Study of Physical Activity and Sedentary Behavior in Adolescents with Obesity

Recruiting
11-18 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the associations between physical activity and sedentary behavior profiles in adolescents with obesity. The focus is on understanding how these behaviors relate to physical fitness and certain structural and vascular parameters, including carotid intima-media thickness (cIMT), a known biomarker for cardiovascular risk.

The study evaluates how different levels of physical activity and sedentary behavior may impact vascular health in adolescents with obesity. It seeks to provide insights into how these factors contribute to cardiovascular risk, emphasizing the importance of understanding these behaviors in this specific population.

  • Who can participate: Adolescents aged 11 to 18 years with a BMI Z-score indicating obesity are eligible to participate. Participants must have parental consent and be covered by a health insurance scheme.
  • Study details: Participants will engage in activities to assess their physical activity and sedentary behavior. The study will measure carotid intima-media thickness (cIMT) to evaluate cardiovascular risk.
Study details
    Obese Adolescents

NCT07811115

University of Avignon

6 October 2026

Contact a study center
Step 1

Consent Answer a 5-minute questionnaire Enter contact details Select a study center Select best time to contact

Informed consent
Introduction
You are being asked to participate in a research study. Before you decide to participate in this study, it is important that you understand why the research is being done and what it will involve. This form is designed to give you the information about the study so you can decide whether to be in the study or not. Please take the time to read the following information carefully. You should ask the researcher if there is anything that is not clear or if you need more information.
Study Participation
If you agree to participate in this study, you will be asked to:
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team
  • Attend screening visit to determine eligibility
  • Attend 6–8 clinic visits over approximately 12 weeks
  • Provide blood samples at designated visits
  • Complete questionnaires about your symptoms and quality of life
  • Take study medication or placebo as directed
  • Report any side effects or health changes to the study team

Preview complete

The prescreener preview is complete. You may now close the preview.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.